Redo high intensity focused U/S may up urinary symptoms

Redo high intensity focused U/S may up urinary symptoms

(HealthDay)—For men with prostate cancer, retreatment with high intensity focused ultrasound is associated with an increase in urinary, but not sexual, side effects, according to a study published in the June issue of The Journal of Urology.

Viktor Berge, M.D., Ph.D., from Oslo University Hospital, and colleagues used United Kingdom registry data on high intensity focused to examine morbidity after primary and redo treatments. Participants included 359 patients who received one whole gland high intensity focused ultrasound treatment for localized , of whom 36.2 percent received retreatment. Patients were followed for a median of 27 months after retreatment. Validated questionnaires were administered before and after ultrasound treatment.

The researchers found that 10.8 and 3.9 percent of patients experienced after the first treatment and retreatment, respectively (P = 0.009). Urethral dilatation was required in 13.8 and 14.0 percent of patients after first and redo ultrasound treatments, respectively (P = 0.7), while bladder neck incision was required in 9.2 and 11.6 percent, respectively (P = 0.2). No leak was reported by 73.3 and 55.1 percent of patients, respectively, before and after retreatment (P < 0.001), and 2.7 and 9.0 percent, respectively, used daily pads (P = 0.07). In analysis of erectile function, no difference was seen in the proportion of who were potent before and after retreatment (56.2 and 56.0 percent, respectively; P = 0.9).

"Redo focused ultrasound is associated with an increase in urinary side effects but sexual side effects do not appear to be significantly increased," the authors write.

Several authors disclosed financial ties to SonaCare Medical.

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Similar outcomes for robotic, laparoscopic prostatectomy

Apr 17, 2013

(HealthDay)—For men undergoing routine surgical treatment for localized cancer of the prostate, robot-assisted radical prostatectomy (RALP) does not result in better functional outcomes compared to laparoscopic ...

Massage enhances fat reduction with cryolipolysis

Jan 17, 2014

(HealthDay)—Post-treatment manual massage improves the efficacy of cryolipolysis on fat reduction, according to a study published online Dec. 11 in Lasers in Surgery and Medicine.

Testosterone therapy doesn't worsen urinary symptoms

Nov 25, 2013

(HealthDay)—For hypogonadal men, testosterone replacement therapy is associated with a low risk of worsening lower urinary tract symptoms, according to a study published in the November issue of The Jo ...

Using microbubbles to improve cancer therapy

Apr 24, 2013

Microbubbles decrease the time and acoustic power of ultrasound required to heat and destroy an embedded target, finds research in BioMed Central's open access journal Journal of Therapeutic Ultrasound. If these results can be ...

Recommended for you

Recorded Ebola deaths top 7,000

18 minutes ago

The worst Ebola outbreak on record has now killed more than 7,000 people, with many of the latest deaths reported in Sierra Leone, the World Health Organization said as United Nations Secretary-General Ban ...

Liberia holds Senate vote amid Ebola fears (Update)

4 hours ago

Health workers manned polling stations across Liberia on Saturday as voters cast their ballots in a twice-delayed Senate election that has been criticized for its potential to spread the deadly Ebola disease.

Evidence-based recs issued for systemic care in psoriasis

Dec 19, 2014

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

Dec 19, 2014

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

Dec 19, 2014

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.